Base: $229,303 to $343,955; bonus/equity: short-te...
10+ years biopharma commercial experience
Phase iii to launch strategic planning
Customer insight generation and analysis
The role involves developing a global strategic plan and operational roadmap for the ETASi asset in Phase III development for Proteinuric CKD
Job Summary
The role involves developing a global strategic plan and operational roadmap for the ETASi asset in Phase III development for Proteinuric CKD.
Candidates must leverage customer insights from patients, physicians, and payers to create differentiated brand strategies aligned with the Integrated CKD strategy.
The position offers a competitive base salary ranging from $229,303 to $343,955 along with short-term incentives, equity programs, and comprehensive health benefits.
Matching Summary
The role involves developing a global strategic plan and operational roadmap for the ETASi asset in Phase III development for Proteinuric CKD.
Salary
Base: $229,303 to $343,955; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation, holidays, leaves, medical, dental, vision coverage
Skills & Requirements
Must-have
10+ years biopharma commercial experience
Phase III to launch strategic planning
Customer insight generation and analysis
Cross-functional global team collaboration
Evidence-based forecasting and business planning
Nice-to-have
Deep CVRM disease area expertise
US specialist launch experience
Experience leveraging AI in commercial strategy
Multiple global market launch experience
Advanced degree (MBA, MSc, or PhD)
Key Requirements
Bachelor's degree required; MBA or advanced degree preferred
Minimum 10 years of commercial marketing experience in biopharma
Specialist launch experience in competitive therapeutic spaces